Logo image of 1ISRG.MI

INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis

Europe - BIT:1ISRG - US46120E6023 - Common Stock

376.05 EUR
-24.7 (-6.16%)
Last: 9/15/2025, 7:00:00 PM
Fundamental Rating

6

Overall 1ISRG gets a fundamental rating of 6 out of 10. We evaluated 1ISRG against 59 industry peers in the Health Care Equipment & Supplies industry. 1ISRG scores excellent points on both the profitability and health parts. This is a solid base for a good stock. 1ISRG shows excellent growth, but is valued quite expensive already. This makes 1ISRG very considerable for growth and quality investing!


Dividend Valuation Growth Profitability Health

Quickly go to:

7

1. Profitability

1.1 Basic Checks

In the past year 1ISRG was profitable.
In the past year 1ISRG had a positive cash flow from operations.
In the past 5 years 1ISRG has always been profitable.
1ISRG had a positive operating cash flow in each of the past 5 years.
1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCF1ISRG.MI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

1.2 Ratios

1ISRG's Return On Assets of 12.93% is amongst the best of the industry. 1ISRG outperforms 88.14% of its industry peers.
Looking at the Return On Equity, with a value of 14.52%, 1ISRG is in the better half of the industry, outperforming 77.97% of the companies in the same industry.
With an excellent Return On Invested Capital value of 11.05%, 1ISRG belongs to the best of the industry, outperforming 83.05% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1ISRG is in line with the industry average of 8.90%.
The 3 year average ROIC (10.15%) for 1ISRG is below the current ROIC(11.05%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 12.93%
ROE 14.52%
ROIC 11.05%
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
1ISRG.MI Yearly ROA, ROE, ROIC1ISRG.MI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

The Profit Margin of 1ISRG (28.51%) is better than 94.92% of its industry peers.
In the last couple of years the Profit Margin of 1ISRG has declined.
1ISRG has a Operating Margin of 28.93%. This is amongst the best in the industry. 1ISRG outperforms 94.92% of its industry peers.
In the last couple of years the Operating Margin of 1ISRG has declined.
1ISRG's Gross Margin of 66.61% is fine compared to the rest of the industry. 1ISRG outperforms 71.19% of its industry peers.
In the last couple of years the Gross Margin of 1ISRG has remained more or less at the same level.
Industry RankSector Rank
OM 28.93%
PM (TTM) 28.51%
GM 66.61%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
1ISRG.MI Yearly Profit, Operating, Gross Margins1ISRG.MI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

More info and screens

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), 1ISRG is creating some value.
Compared to 1 year ago, 1ISRG has more shares outstanding
Compared to 5 years ago, 1ISRG has more shares outstanding
1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
1ISRG.MI Yearly Shares Outstanding1ISRG.MI Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
1ISRG.MI Yearly Total Debt VS Total Assets1ISRG.MI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.2 Solvency

1ISRG has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z N/A
ROIC/WACC1.27
WACC8.7%
1ISRG.MI Yearly LT Debt VS Equity VS FCF1ISRG.MI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B

2.3 Liquidity

1ISRG has a Current Ratio of 5.64. This indicates that 1ISRG is financially healthy and has no problem in meeting its short term obligations.
1ISRG's Current ratio of 5.64 is amongst the best of the industry. 1ISRG outperforms 98.31% of its industry peers.
A Quick Ratio of 4.89 indicates that 1ISRG has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.89, 1ISRG belongs to the best of the industry, outperforming 98.31% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.64
Quick Ratio 4.89
1ISRG.MI Yearly Current Assets VS Current Liabilites1ISRG.MI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 26.97% over the past year.
1ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
The Revenue has grown by 20.77% in the past year. This is a very strong growth!
1ISRG shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 13.27% yearly.
EPS 1Y (TTM)26.97%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%23.03%
Revenue 1Y (TTM)20.77%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%21.4%

3.2 Future

1ISRG is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 14.53% yearly.
The Revenue is expected to grow by 14.89% on average over the next years. This is quite good.
EPS Next Y13.56%
EPS Next 2Y13.58%
EPS Next 3Y14.55%
EPS Next 5Y14.53%
Revenue Next Year19.71%
Revenue Next 2Y17.08%
Revenue Next 3Y16.39%
Revenue Next 5Y14.89%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
1ISRG.MI Yearly Revenue VS Estimates1ISRG.MI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5B 10B 15B 20B
1ISRG.MI Yearly EPS VS Estimates1ISRG.MI Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10 15

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 54.74, the valuation of 1ISRG can be described as expensive.
Compared to the rest of the industry, the Price/Earnings ratio of 1ISRG is on the same level as its industry peers.
1ISRG is valuated expensively when we compare the Price/Earnings ratio to 27.20, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 46.60, the valuation of 1ISRG can be described as expensive.
62.71% of the companies in the same industry are cheaper than 1ISRG, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.71, 1ISRG is valued quite expensively.
Industry RankSector Rank
PE 54.74
Fwd PE 46.6
1ISRG.MI Price Earnings VS Forward Price Earnings1ISRG.MI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, 1ISRG is valued a bit more expensive than the industry average as 67.80% of the companies are valued more cheaply.
1ISRG's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 79.21
EV/EBITDA 49.28
1ISRG.MI Per share data1ISRG.MI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates 1ISRG does not grow enough to justify the current Price/Earnings ratio.
1ISRG has a very decent profitability rating, which may justify a higher PE ratio.
A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 14.55% in the coming years.
PEG (NY)4.04
PEG (5Y)4.77
EPS Next 2Y13.58%
EPS Next 3Y14.55%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for 1ISRG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

INTUITIVE SURGICAL INC

BIT:1ISRG (9/15/2025, 7:00:00 PM)

376.05

-24.7 (-6.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)07-22 2025-07-22/amc
Earnings (Next)10-15 2025-10-15/amc
Inst Owners88.73%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap134.81B
Analysts79
Price Target502.95 (33.75%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.33%
Min EPS beat(2)3.05%
Max EPS beat(2)11.61%
EPS beat(4)4
Avg EPS beat(4)11.45%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)8.83%
EPS beat(12)11
Avg EPS beat(12)6.4%
EPS beat(16)13
Avg EPS beat(16)4.58%
Revenue beat(2)2
Avg Revenue beat(2)1.47%
Min Revenue beat(2)1.09%
Max Revenue beat(2)1.84%
Revenue beat(4)3
Avg Revenue beat(4)1.98%
Min Revenue beat(4)-0.14%
Max Revenue beat(4)5.12%
Revenue beat(8)4
Avg Revenue beat(8)0.5%
Revenue beat(12)6
Avg Revenue beat(12)0.42%
Revenue beat(16)7
Avg Revenue beat(16)0.13%
PT rev (1m)-1.33%
PT rev (3m)-4.44%
EPS NQ rev (1m)0.11%
EPS NQ rev (3m)2.12%
EPS NY rev (1m)4.08%
EPS NY rev (3m)4.34%
Revenue NQ rev (1m)0.08%
Revenue NQ rev (3m)0.82%
Revenue NY rev (1m)0.13%
Revenue NY rev (3m)1.38%
Valuation
Industry RankSector Rank
PE 54.74
Fwd PE 46.6
P/S 17.27
P/FCF 79.21
P/OCF 55.9
P/B 8.8
P/tB 8.97
EV/EBITDA 49.28
EPS(TTM)6.87
EY1.83%
EPS(NY)8.07
Fwd EY2.15%
FCF(TTM)4.75
FCFY1.26%
OCF(TTM)6.73
OCFY1.79%
SpS21.77
BVpS42.74
TBVpS41.91
PEG (NY)4.04
PEG (5Y)4.77
Profitability
Industry RankSector Rank
ROA 12.93%
ROE 14.52%
ROCE 14.74%
ROIC 11.05%
ROICexc 23.57%
ROICexgc 24.58%
OM 28.93%
PM (TTM) 28.51%
GM 66.61%
FCFM 21.81%
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
ROICexc(3y)15.35%
ROICexc(5y)15.85%
ROICexgc(3y)16.06%
ROICexgc(5y)16.75%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexcg growth 3Y-7.59%
ROICexcg growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 144.66%
Cap/Sales 9.1%
Interest Coverage 250
Cash Conversion 87.74%
Profit Quality 76.48%
Current Ratio 5.64
Quick Ratio 4.89
Altman-Z N/A
F-Score6
WACC8.7%
ROIC/WACC1.27
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)26.97%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%23.03%
EPS Next Y13.56%
EPS Next 2Y13.58%
EPS Next 3Y14.55%
EPS Next 5Y14.53%
Revenue 1Y (TTM)20.77%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%21.4%
Revenue Next Year19.71%
Revenue Next 2Y17.08%
Revenue Next 3Y16.39%
Revenue Next 5Y14.89%
EBIT growth 1Y34.69%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year40.01%
EBIT Next 3Y23.31%
EBIT Next 5Y20.2%
FCF growth 1Y69.15%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y52.09%
OCF growth 3Y4.95%
OCF growth 5Y8.61%